Northwest Biotherapeutics Inc. sold 5.0 million common shares at 20 cents apiece to an unaffiliated investor.
The company also issued to the investor 2.5 million class D warrants exercisable at 23 cents per share for a period of two years, and 2.5 million class D warrants exercisable at 30 cents per share for a period of two years, for an aggregate of $1.0 million.